HealthCare Global Enterprises Price/Sales
What is the Price/Sales of HealthCare Global Enterprises?
The Price/Sales of HealthCare Global Enterprises Limited is 2.76
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Health Care sector on NSE compared to HealthCare Global Enterprises
What does HealthCare Global Enterprises do?
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2022, the company operated 22 comprehensive cancer centers, including 1 center in Africa. The company was founded in 1989 and is based in Bengaluru, India.
Companies with price/sales similar to HealthCare Global Enterprises
- Castrol India has Price/Sales of 2.76
- Marriott International has Price/Sales of 2.76
- Zynex Inc has Price/Sales of 2.76
- Recon Technology Ltd has Price/Sales of 2.76
- Riskified has Price/Sales of 2.76
- Tortoise Midstream Fund Inc has Price/Sales of 2.76
- HealthCare Global Enterprises has Price/Sales of 2.76
- The Karur Vysya Bank has Price/Sales of 2.76
- CSPC Pharmaceutical has Price/Sales of 2.76
- Cohen & Steers Quality Income Realty Fund has Price/Sales of 2.76
- WEX Inc has Price/Sales of 2.76
- Santos has Price/Sales of 2.76
- Beam Global has Price/Sales of 2.76